Skip to main content

AI nutrition apps that promise a diet tailored to your genes, gut bacteria or blood sugar responses have weaker evidence than their marketing suggests. Randomized trials show people do vary in how they respond to food, but personalized plans have mostly failed to beat good general dietary advice on weight. The best-supported benefit is simpler: regular, specific feedback that helps you actually change what you eat.

In 2015 a team at the Weizmann Institute in Israel published a study in the journal Cell that changed how many people think about food. They fitted 800 volunteers with glucose monitors and found that people’s blood sugar responses to identical meals varied widely. One person’s spike after bread was another person’s spike after bananas. They then trained an algorithm, using data including gut bacteria, that predicted individual responses better than counting carbohydrates.

The implication seemed obvious. If our bodies respond differently, we need different diets, and a machine can work out which one is yours. An industry followed: apps, home test kits, glucose sensors for people without diabetes, AI coaches that score your meals.

Here is the argument of this piece. The biology of individual variation is real. The claim that AI-personalized diets produce better health outcomes than sound general advice is, for most products, still ahead of the evidence. What seems to work is not the personalization so much as the coaching: frequent, concrete feedback that keeps people engaged. That distinction matters when you are deciding what to pay for.

What does an AI nutrition app actually do?

The category is broad, and it helps to separate three kinds of product.

Tracking and coaching apps log what you eat, often from a photo, estimate nutrients and give feedback or nudges. Many now use large language models to answer questions conversationally.

Biomarker-based personalization uses data from your body, such as continuous glucose monitor readings, blood fats, gut microbiome tests or genetic tests, to score foods for you specifically.

AI meal planners generate recipes and shopping lists based on your stated preferences, goals and restrictions.

The first and third are convenience tools. The second makes the boldest claim: that your biology requires a diet different from general guidance. That claim is testable, and several randomized trials have tested it.

Do personalized diets work better than standard advice?

The honest answer so far is: sometimes a little, often not at all, and rarely on weight.

Genes did not predict who lost weight. The DIETFITS trial at Stanford, published in JAMA in 2018, randomized 609 adults to a healthy low-fat or healthy low-carbohydrate diet for a year. The researchers also tested whether a genetic pattern thought to predict response, or a measure of insulin secretion, identified who would do better on which diet. Neither did. Both groups lost similar amounts of weight, and the supposed predictors made no meaningful difference.

Personalized advice helped, but biology added little. The Food4Me trial, a European study of more than 1,600 adults across seven countries published in the International Journal of Epidemiology in 2017, compared generic dietary advice with advice personalized at increasing levels of detail. Personalized advice led to bigger improvements in diet than generic advice. But adding information about participants’ blood markers or genes did not make the advice more effective than personalization based on what people were actually eating.

A glucose-based diet did not beat a low-fat one. The Personal Diet Study, published in JAMA Network Open in 2022 by Popp and colleagues, randomized adults with obesity and abnormal glucose metabolism to a diet personalized by an algorithm to reduce their blood sugar spikes, or to a standard low-fat diet. After six months, weight loss was not greater in the personalized group. A follow-up analysis found no greater improvement in glucose variability or HbA1c either.

A commercial program showed some benefits. The most favourable trial for the industry was published in Nature Medicine in 2024 by Bermingham and colleagues, run by the company behind a personalized nutrition program. It randomized 347 adults to an 18-week app-based program using glucose and blood-fat responses, microbiome data and health history, or to general dietary advice. Triglycerides fell significantly more in the personalized group, but the difference in LDL cholesterol, the other primary outcome, was not significant. Secondary outcomes such as weight and waist size improved. Critics pointed out that the control group received general advice rather than an equally intensive app-based program, which makes it hard to know whether the personalization or the engagement did the work.

Put together, the trials tell a consistent story. Tailoring advice to what people really eat helps. Tailoring it to genes or glucose curves has not yet shown clear added value for most outcomes that matter.

Why do personalization claims outrun the evidence?

Part of the answer is how the science translates into products.

The Weizmann study showed that people differ in blood sugar spikes after meals. That is a real, measurable finding. But a short-term glucose spike is a proxy. It is not the same as weight, heart disease, diabetes or death. A diet that flattens your personal glucose curve may or may not improve those outcomes, and the trials above suggest the effect, if any, is modest.

A second reason is the comparison group. An app that tracks your meals, messages you daily and shows you graphs is more engaging than a leaflet. If a trial compares the app with a leaflet, the app will often win, and marketing will credit the algorithm. The fairer test compares personalization against equally intensive general coaching. Those trials are rarer, and when they are done, as with DIETFITS, the biology usually does not add much.

A third reason is that continuous glucose monitors, designed for people with diabetes, have become consumer gadgets for people without it. That creates a lot of data, and data invites interpretation. We have argued that wearables data amounts to a screening programme nobody designed. Glucose monitoring in healthy people fits that description: plenty of readings, little agreement on what normal fluctuation should prompt.

A worked example: what a personalized plan might change

This example is hypothetical.

Daniel, 48, wants to lose weight and is told his blood sugar is slightly raised. He buys a subscription that includes two weeks of glucose monitoring and a microbiome test. The app tells him oats spike his glucose and suggests eggs instead, flags that he eats late, and gives each meal a score.

Over three months he loses five kilograms. He is convinced the personalization worked.

It may have. But look at what else happened. He started logging every meal. He thought about food several times a day. He cut late-night snacks because the app scored them poorly. He ate more vegetables because they scored well for everyone. All of those changes are consistent with standard advice, and the trials suggest they, rather than the oats-versus-eggs insight, probably did most of the work.

None of that makes his result less real. It does change the purchasing question. If the benefit comes mostly from attention and feedback, a cheaper tracking tool, a dietitian, or a structured programme may deliver much of the same. And if his blood sugar is raised, the right next step is a conversation with his clinician, not an app alone. Diabetes prevention programs have a stronger evidence base, as we discussed in what diabetes prevention looks like at scale.

The strongest case for AI nutrition coaching

The best argument for these tools is not about biology. It is about behaviour.

Most people know roughly what a healthy diet looks like. The hard part is doing it, every day, for years. Dietitians are scarce and expensive, and a monthly appointment is a weak lever against three meals a day. A tool that is always in your pocket, gives immediate feedback and adapts its suggestions to your tastes could fill a real gap. Food4Me suggests personalization based on what people actually eat does improve diet. AI makes that kind of feedback much cheaper to deliver.

That argument is sound, and it points to where the value probably lies: in coaching and adherence, not in molecular precision. The risk is paying a premium for the biology while getting the benefit from the habit.

What should you check before using an AI nutrition app?

A few questions help separate useful tools from expensive ones. They are general guidance, not a substitute for advice from a clinician or registered dietitian.

What outcome has it been tested on? Look for randomized trials measuring weight, blood pressure, HbA1c or cholesterol, not just glucose spikes or user satisfaction.

What was the comparison? A trial against a leaflet tells you less than a trial against equally intensive coaching.

Who ran the study? Company-funded research can be sound, but independent replication matters.

Is it safe for you? People with diabetes on insulin or other glucose-lowering drugs, pregnant people, people with kidney disease and anyone with a history of eating disorders should talk to their clinician before following an app’s diet advice. Some apps’ scoring systems can reinforce restrictive eating.

What happens to your data? Microbiome, genetic and glucose data are sensitive. Check whether they are shared or sold.

What this means for consumers, clinicians and companies

For consumers. Treat personalization claims with polite scepticism. If an app helps you eat better consistently, that is a genuine benefit, but it is probably coming from the habit, not the genome. For any medical condition, involve your clinician.

For clinicians. Patients will arrive with glucose graphs and food scores. The useful response is to redirect attention to outcomes that matter and to proven interventions, including medicines such as GLP-1 drugs where appropriate, a topic we covered in the GLP-1 equity problem.

For companies. The field needs trials that compare personalization with equally engaging general coaching over a year or more, on hard outcomes. Until then, “personalized” describes the product, not the proof.

Frequently asked questions

Do AI nutrition apps help you lose weight?

Some people lose weight using them, mainly because tracking and regular feedback help change habits. Randomized trials have not consistently shown that diets personalized by genes, microbiome or glucose responses produce more weight loss than good general advice. The 2018 DIETFITS and 2022 Personal Diet Study trials both found no clear advantage for personalization on weight.

Is a diet based on my DNA better than a standard healthy diet?

Current evidence says generally not. The Stanford DIETFITS trial found that a genetic pattern thought to predict diet response did not identify who lost more weight. The European Food4Me trial found that adding genetic information did not make personalized advice more effective than advice based on what people actually ate.

Should people without diabetes wear a glucose monitor to guide their diet?

The evidence that this improves long-term health in people without diabetes is limited. Glucose rises after meals are normal, and it is not established that flattening them improves outcomes such as weight or heart disease. If you are concerned about blood sugar, ask your clinician about appropriate testing instead of relying on a consumer device.

Are AI health coaches safe?

For most healthy adults, general diet coaching carries little direct risk, though the advice can be wrong. People with diabetes on medication, kidney disease, pregnancy or a history of eating disorders should consult their clinician first, because diet changes can interact with treatment or reinforce harmful patterns. AI coaching is not a substitute for medical care.

What is the evidence behind personalized nutrition?

Studies such as the Weizmann Institute’s 2015 Cell paper show people’s metabolic responses to food vary. Trials testing whether personalized diets improve outcomes are more mixed: a 2024 Nature Medicine trial found lower triglycerides but no significant LDL change, while other trials found no weight advantage.

Your response to a banana may be unique. The advice that actually helps you, eat more plants, fewer ultra-processed foods and keep at it, mostly is not. Pay for the coaching if it keeps you going; be sceptical of paying for the mystique.

Have you tried a personalized nutrition app? Was it the insights or the habit that made the difference?

Abhishek Shankar

Abhishek Shankar is a three-time founder and CEO of MyBabyBridge, which uses AI and data to make IVF more accessible. He writes about the gap between what works in health pilots and what survives at scale, covering financing, workforce, digital health and equity. He writes more at abhishek-shankar.com.

Leave a Reply